Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Verve Therapeutics Inc
(NQ:
VERV
)
6.080
-0.620 (-9.25%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Verve Therapeutics Inc
< Previous
1
2
3
4
5
6
7
8
Next >
12 Health Care Stocks Moving In Monday's Intraday Session
November 07, 2022
Gainers
Via
Benzinga
Why Oyster Point Pharma Shares Are Trading Higher By Around 40%? Here Are 49 Stocks Moving In Monday's Mid-Day Session
November 07, 2022
Gainers Dragon Victory International Limited (NASDAQ: LYL) surged 52.2% to $0.6870.
Via
Benzinga
Looking Into Verve Therapeutics's Recent Short Interest
November 07, 2022
Verve Therapeutics's (NASDAQ:VERV) short percent of float has fallen 11.53% since its last report. The company recently reported that it has 10.73 million shares sold short, which is 33.6% of all...
Via
Benzinga
Why Shares Of CRISPR-Focused Verve Therapeutics Just Took A Grim Turn
October 31, 2022
The company is testing a CRISPR-based approach to high cholesterol.
Via
Investor's Business Daily
Dow Jumps Over 200 Points; Verve Therapeutics Shares Plummet
November 07, 2022
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 200 points on Monday.
Via
Benzinga
Dow Up Triple Digits Ahead Of Busy Week
November 07, 2022
The Dow Jones Industrial Average is up 212 points midday, continuing Friday's flourish, while the Nasdaq Composite and S&P 500 Index sit more hesitantly in the black.
Via
Talk Markets
IAA Stock Moves as Ritchie Bros Acquires Company in $7.3 Billion Deal
November 07, 2022
IAA (IAA) stock is moving on Monday thanks to a massive acquisition $7.3 billion deal with Ritchie Bros Auctioneers (RBA).
Via
InvestorPlace
Verve Therapeutics Shares Tumble After FDA Hold On Trial For Elevated Cholesterol Level Candidate
November 07, 2022
Via
Benzinga
Why Is Verve Therapeutics (VERV) Stock Down 28% Today?
November 07, 2022
Verve Therapeutics (VERV) stock is taking a beating on Monday following bad news from the U.S. Food and Drug Administration (FDA).
Via
InvestorPlace
TreeHouse Foods, Ritchie Bros. Auctioneers, Beam Therapeutics And Some Other Big Stocks Moving Lower On Monday
November 07, 2022
U.S. stocks traded mostly higher, with the Dow Jones gaining more than 150 points on Monday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
US Stocks Mixed; Dow Rises Over 50 Points
November 07, 2022
U.S. stocks traded mixed this morning, with the Dow Jones gaining over 50 points on Monday.
Via
Benzinga
Verve Crashes After FDA Halts Plan To Test Gene Editor In People
November 07, 2022
Verve Therapeutics hopes to use a next-generation form of CRISPR called base editing.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 07, 2022
Gainers Cidara Therapeutics (NASDAQ:CDTX) shares rose 14.6% to $0.64 during Monday's pre-market session. The market value of their outstanding shares is at $44.9 million. The company's, Q3 earnings...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
November 07, 2022
Good morning, investor! We're diving into the biggest pre-market stock movers for Monday as we get ready for another week of trading!
Via
InvestorPlace
CRISPR Stocks: Will Concerns Over Risk Inhibit Gene-Editing Cures?
October 20, 2022
Despite enthusiasm in some camps, the risk of potential cures clouds market projections.
Via
Investor's Business Daily
A Look Into Healthcare Sector Value Stocks
October 10, 2022
What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base...
Via
Benzinga
Verve's Stock Price Could Continue To Rise Through Clinical Progress - Despite Worries About "DeeperPocketed" Competition
October 06, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2022
October 06, 2022
Upgrades
Via
Benzinga
Cathie Wood Just Bought the TSLA Stock Dip. Should You?
October 04, 2022
Cathie Wood is doubling down on TSLA stock. Here's why investors may want to follow her lead before markets shift in 2023.
Via
InvestorPlace
A Look Into Healthcare Sector Value Stocks
October 03, 2022
The Meaning Behind Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base...
Via
Benzinga
5 Top Stocks Cathie Wood Is Buying This Week
September 30, 2022
There's a new Ark fund in town, and its name is the ARK Venture Fund. It will capitalize on democratizing private investments to the public.
Via
InvestorPlace
Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday
September 28, 2022
Gainers
Via
Benzinga
Why Bellerophon Therapeutics Shares Are Trading Higher By 24%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session
September 27, 2022
Gainers
Via
Benzinga
Amazon, bluebird bio And 3 Stocks To Watch Heading Into Monday
September 26, 2022
With US stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Cathie Wood Loads Up $23M Worth Of Shares In This Gene-Editing Company As Stock Falls Over 10% In A Month
September 25, 2022
Cathie Wood-led Ark Investment Management on Friday raised its stake in clinical stage genetics medicine company Verve Therapeutics Inc (NASDAQ: VERV) via two of its exchange-traded funds.
Via
Benzinga
The Top 5 Stocks Cathie Wood Is Buying This Week
September 23, 2022
Cathie Wood announced that she would step down as portfolio manager for PRNT and IZRL. That hasn't stopped her from making her usual buys.
Via
InvestorPlace
Ionis Pharmaceuticals Nosedives After AstraZeneca Drops High Cholesterol Drug Test
September 23, 2022
Though successful in early testing, it wasn't enough to win a Phase 3 study.
Via
Investor's Business Daily
5 Top Stocks Cathie Wood Is Buying Right Now
September 19, 2022
Cathie Wood's ARKK is down over 50% YTD, although the fund manager is still continuing her purchases of high conviction companies.
Via
InvestorPlace
FedEx, NCR, International Paper And Other Big Losers From Friday
September 19, 2022
U.S. stocks closed lower with the Nasdaq Composite dropping over 100 points on Friday. Here is the list of some big stocks recording losses in the previous session.
Via
Benzinga
Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday
September 19, 2022
Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.